이수앱지스

086890KOSDAQSector: Pharma & Biotech

₩3,100▲ 0.32%Market cap ₩126.4BAs of Jul 21, 2026 close · updated once daily

Grade C49.5 ptsTop 55% of 2,523 stocks

Financial strength

56.1

Growth momentum

47.1

Price attractiveness

43.7

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

56.1

How much debt does it carry relative to equity?

Debt-to-equity ratio

38.8%

✓ Above median · Top 35.6% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

193.1%

✓ Above median · Top 48.6% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

2.9%

✓ Above median · Top 37.2% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-9.3%

✗ Below median · Top 54.3% in sector

Sector median -4.5%

Source filing: annual report (separate) — view original ↗

Growth momentum

47.1

How much did revenue grow in a year?

Revenue growth (YoY)

-6.0%

✗ Below median · Top 75.1% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

11.2%

✓ Above median · Top 29.9% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

-87.8%

✗ Below median · Top 90.4% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

110.2%

✓ Above median · Top 16.4% in sector

Sector median 3.5%

Source filing: annual report (separate) — view original ↗

Price attractiveness

43.7

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 68.5% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

1.10x

✓ Above median · Top 44.1% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15